$89.330
-1.018 (-1.14%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
SYRE 相似图表分析预测
Alphio's SYRE stock price prediction model matches the current Spyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $88.38 (-0.14%). The 1-week path is $89.11 (+0.69%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Spyre Therapeutics Inc 股票吗？
Spyre Therapeutics Inc is currently not a good buy. The stock is trading at $90.36, with a 5-day change of -15.15% and an RSI of 16.467, indicating it is oversold. Despite a strong year-to-date change of +195.49% and a one-year change of +443.36%, the recent insider selling and downgrades in analyst price targets suggest caution. The main risk is the significant net losses, with a reported net income of -$69 million for Q1 2026, which raises concerns about sustainability.
SYRE 股价于 Monday 收于 $89.33，此前下跌 -1.14%
Spyre Therapeutics Inc (SYRE) last closed at $88.5, losing -0.93%. These facts feed the 1-day and 1-week SYRE price prediction above.
预测驱动因素
Spyre Therapeutics Inc（SYRE）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
相似图表形态
近期走势与 SYRE 最接近的股票，按相似度排序。
SYRE 季节性分析
Historically the probability of a positive September return for SYRE is 50.00%. December offers the highest probability of a positive month at 100.00%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。